PI3K inhibitors Flashcards

1
Q

What is the general substrate of PI3K

A

phosphatidyl-inositol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where can the inositol head group be phosphorylated

A

3,4,5 free OH groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which OH groups cannot be phosphorylated on the inositol head group of PI

A

Positions 2 and 6

Nor 1 because it’s already bound to the phosphate group linking it to the DAG lipid anchor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What determines where a phosphorylated PtdIns will localise intracellularly?

A

The positions in which it is phosphorylated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does PI3P concentration change in response to growth factor stimulation

A

Doesn’t change, considered to be constitutive lipid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do PIP3 and PI(3,4)P2 concentrations change after growth factor stimulation

A

Levels of the lipids rise rapidly following growth factor stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the result of a PtdIns being phosphorylated at the 3-OH position?

A

It’s no longer a substrate for phospholipase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What kind of proteins do PIP3 and PI(3,4)P2 bind to

A

Proteins with a plextrin homology domain which is found in protein kinases, adaptor proteins and regulators of small GTPases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What protein domains do PI(3)P bind to? and where are these found?

A

FYVE - Mostly in proteins involved in membrane trafficking

PX - in proteins that regulate NADPH oxidase complex, endocytic trafficking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the four members of the class I PI3K isoforms

A

p110alpha/PIK3CA, p110beta/delta/gamma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the 3 members of the class II PI3Ks

A

C2alpha, C2beta, C2gamma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the class III PI3K

A

vps34

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the substrate of the class I PI3Ks and what do they produce from it

A

PI(4,5)P2 is the substrate and it forms PIP3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does PIP3 bind to downstream protein substrates

A

Via the proteins PH domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the substrate of class II/III PI3Ks

A

PI and converts it to PI(3)P which binds its target proteins by FYVE and PX domains.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is there a delay in the production of PI(3,4)P2 compared to PI(3,4,5)P3 following growth factor stimulation?

A

PIP3 is produced first, then through the action of 5-phosphatase PIP3 is used to make PI(3,4)P2

17
Q

What are the class 1A PI3Ks

A

p110alpha, beta and delta

18
Q

what is the class 1B isoform of PI3K

A

p110 gamma

19
Q

How are class 1A PI3Ks activated?

A

By tyrosine kinase receptors, the SH2 domain of the regulatory subunit on each isoform binds to the phosphorylated kinase domain on the tyrosine kinase
Also activated by Ras/Rac/cdc42

20
Q

How are class 1B PI3Ks activated?

A

By GPCRs, also by Ras/Rac/cdc42

21
Q

What is the lipid phosphatase that regulates the production of PIP3

A

PTEN

22
Q

Which position on PIP3 is dephosphorylated by PTEN

A

At the 3 position

23
Q

Can PI3K signalling cause treatment resistance

A

Yes, following hormonal therapy, chemotherapy, radiotherapy and targeted agents

24
Q

Which parts of the PI3K pathway often become mutated in cancer

A

Oncogenic tyrosine kinases and Ras
PIK3CA/p110 alpha frequently mutated in cancers
Akt/PKB is activated as a result of mutation or upstream PI3K activation

25
Q

What are the hotspots in which PIK3CA becomes mutated in solid tumours?

A

The helical domain and the kinase domain.

26
Q

What kind of mutations are found in PIK3CA in segmental overgrowth syndromes?

A

Mosaic mutations in PIK3CA during embryonic development

27
Q

Why does the inhibition of mTORC1 using rapamycin actually increase the amount of PI3K signalling

A

Because: Downstream of mTORC1 is s6K1, a kinase which inhibits IRS-1 which is responsible for PI3K activation. By inhibiting mTORC1, this negative feedback loop no longer functions and PI3K signalling is switched on and other targets of AKT can be targeted (not just mTOR)

28
Q

Can cells survive with a low amount of PI3K activity? and does this effect proliferation?

A

Cells can survive and proliferate normally with <10% of their class 1A PI3K activity

29
Q

What kind of PI3K inhibitor is Piqray?

A

A p110 alpha inhibitor.

30
Q

What combination therapy is used in ER+ breast cancer with Piqray and why is this the case?

A

p110 alpha inhibitors in ER+ breast cancer increases the expression of ER. Therefore, when combined with hormonal therapy there is a synergistic effect on tumour regression

31
Q

Where is p110 delta mainly expressed?

A

Leukocytes

32
Q

Does PI3K delta expression increase in leukemic cells compared to normal ones?

A

No, its present at high levels in both cell types

33
Q

In leukemia, is PI3K delta mutated?

A

Very rarely

34
Q

Which specific haem-malignancies are PI3Kdelta inhibitors effective in

A

B cell malignancies. Specifically B cell chronic lymphocytic leukaemia (CLL) and B cell follicular lymphoma

35
Q

Why is PI3Kdelta inhibition only effective in B cell malignancies?

A

In CLL, B-cells have a particular life cycle, going between the lymph nodes and bone marrow and then into circulation. To access the lymph nodes/bone marrow they respond to chemokines, to stay they resond to adhesion molecules, for co stimulation they respond to B-cell antigen receptors; all of which rely on PI3K delta. If this is blocked, the cells can no longer respond to the signals and accumulate in the circulation. In the circulation they are vulnerable to combination therapy (anti CD20 immunotherapy)

36
Q

Why are normal B cells dependent on PI3Kdelta for survival?

A

Signalling through adhesion molecules, chemokines, co-stimulatory molecules and B-cell antigen receptors all rely on PI3K delta for the modulation of these signals

37
Q

Are PI3K delta inhibitors responsible for the cytotoxic effect on B-cells

A

No, only make them vulnerable to the therapy used in combination

38
Q

What effect does PI3K delta inhibition have on different T cell populations and what effect does this have on solid tumours?

A

Greatly inhibits Tregs whilst only having a limited inhibition on effector T cells (Th and cytotoxic T cells) This tips the balance towards an active, anti-cancer response.